What is the primary focus of the consolidation phase in chemotherapy?

The consolidation phase in chemotherapy is primarily focused on killing any remaining cancer cells that may be present in the body after the initial treatment, known as induction therapy, has been completed. This phase is crucial because, although induction therapy aims to rapidly reduce the number of cancer cells, some may persist and lead to relapse if not adequately addressed. The consolidation phase serves to further decrease the risk of cancer recurrence by ensuring that any residual disease is targeted and eliminated.

This focus on eradicating remaining cancer cells differentiates it from other potential treatments or supports, like enhancing radiation effects or preparing for stem cell transplants. While reducing side effects is an important consideration in the administration of chemotherapy, it is not the primary goal of the consolidation phase. Instead, the aim is firmly centered around maximizing cancer cell kill to secure better long-term outcomes for the patient.